This content is machine translated Research highlights in atopic dermatitis Innovative therapies – Update 2024 The arsenal of currently researched active substances in the indication area of atopic dermatitis (AD) is considerable. In addition to anti-OX40/OX40L antibodies, CM310, nemolizumab and neurokinin receptor 1 antagonists, there…
View Post 6 min This content is machine translated Chronic prurigo Antipruritic therapy alleviates suffering Chronic prurigo is associated with persistent papules and nodules on the skin and is now defined as a disease in its own right. However, this was not always the case:…
View Post 6 min This content is machine translated Prurigo nodularis Inflammation-promoting pruritogenic cytokines as a therapeutic target There are various triggers for the initial itching in prurigo nodularis (PN). If those affected give in to the scratching impulse, the pruritus intensifies, as this stimulates nerve and inflammatory…
View Post 5 min This content is machine translated Prurigo nodularis New therapeutic approaches are promising Recent research findings indicate that Th2-associated immune cells and cytokines play an important role in the pathogenesis of prurigo nodularis (PN). This is the therapeutic target of the two biologics,…
View Post 6 min This content is machine translated Chronic itching Non-trivial – despite proven and new system therapies Chronic pruritus can occur at any age and affect different groups of patients. A guideline-based approach is advisable in order to determine the cause and provide the best possible treatment…
View Post 4 min This content is machine translated Prurigo nodularis When excruciating itching proves to be persistent – what helps? Chronic prurigo is characterized by an “itch-scratch cycle” and is often associated with high levels of distress. The International Forum for the Study of Itch (IFSI) suggests a stage-adapted multimodal…
